Back to search
FDAFDA · Food and drugs·Recall number Z-2033-2017

Destination Renal Guiding Sheath Intended for the introduction of interventional and diagnostic devices into the human vasculature.

Published May 10, 2017 · Recall initiated: November 6, 2015

Summary

FDA records medical device Class II recall Z-2033-2017, published May 10, 2017 and initiated November 6, 2015. Recalling firm: Terumo Medical Corporation; Status: Terminated; Reported quantity: 5,252 eaches; Lot: Terumo Product Code - RSR01 Affected Lot Numbers RN19 RN26 RP03. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Based on internal investigation and testing that revealed the distal end of certain lots of Terumo Medical Destination® products may not contain the labeled 5 cm of coating. While there have been no complaints or patient related incidents reported, the lack of coating could render it difficult to navigate the device to the target vasculature.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Terumo Medical Corporation
Distributor
Nationwide Distribution.
Lot
Terumo Product Code - RSR01 Affected Lot Numbers RN19 RN26 RP03
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Destination Renal Guiding Sheath Intended for the introduction of interventional and diagnostic devices into the human vasculature. recalled?

Yes. FDA published recall Z-2033-2017 on May 10, 2017. Reported hazard: Based on internal investigation and testing that revealed the distal end of certain lots of Terumo Medical Destination® products may not contain the labeled 5 cm of coating. While there have been no complaints or patient related incidents reported, the lack of coating could render it difficult to navigate the device to the target vasculature.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail